Abstract
This thesis expands the evidence base for the long-term outcomes of children and adolescents with Cerebral Palsy (CP) treated with Botulinum toxin (BoNTA). A cohort of children with CP in WA who have been managed with BoNTA since 1995 were studied and our results confirm long-term use of BoNTA is associated with gross motor stability when used within evidence-based guidelines and in a model of goal-based decision making by a multidisciplinary team. It is important to consider dose and frequency to ensure muscle recovery from the neurogenic atrophy effects of BoNTA and ensure muscle strength is maximised post BoNTA use.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 2 Jan 2020 |
DOIs | |
Publication status | Unpublished - 2020 |